Jason Silvers insider trades

Open-market stock purchases and sales by Jason Silvers, President & CFO at Generate Biomedicines, Inc, from SEC Form 4 filings since Feb 26, 2026.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -20%.

Recent trades

DateStockTradeValue
Mar 2, 2026GENB Generate Biomedicines, IncBought$8K
Mar 2, 2026GENB Generate Biomedicines, IncBought$16K
Feb 26, 2026GENB Generate Biomedicines, IncBought (not open market)—
Feb 26, 2026GENB Generate Biomedicines, IncBought (not open market)—

Companies traded

  • GENB Generate Biomedicines, Inc: 2 buys, last Mar 2, 2026

Get free alerts when Jason Silvers files a new trade →